tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market

Neuphoria Therapeutics (NEUP) Technical Analysis

Compare
240 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Neuphoria Therapeutics’s (NEUP) Moving Averages Convergence Divergence (MACD) indicator is 0.51, suggesting Neuphoria Therapeutics is a Sell.
Neuphoria Therapeutics’s (NEUP) 20-Day exponential moving average is 6.25, while Neuphoria Therapeutics’s (NEUP) share price is $6.87, making it a Buy.
Neuphoria Therapeutics’s (NEUP) 50-Day exponential moving average is 5.67, while Neuphoria Therapeutics’s (NEUP) share price is $6.87, making it a Buy.

Neuphoria Therapeutics (NEUP) Pivot Points

Jun 09, 2025, 07:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.72
6.88
7.02
7.18
7.31
7.47
7.61
Fibonacci
6.88
6.99
7.06
7.18
7.29
7.36
7.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neuphoria Therapeutics (NEUP) Moving Averages

Jun 09, 2025, 07:27 AM
Period
Simple
Exponential
MA5
7.01Sell
6.93Sell
MA10
6.82Buy
6.69Buy
MA20
5.99Buy
6.25Buy
MA50
5.50Buy
5.67Buy
MA100
5.15Buy
5.37Buy
MA200
4.93Buy
5.61Buy
Neuphoria Therapeutics’s (NEUP) 10-Day exponential moving average is 6.69, while Neuphoria Therapeutics’s (NEUP) share price is $6.87, making it a Buy.
Neuphoria Therapeutics’s (NEUP) 100-Day exponential moving average is 5.37, while Neuphoria Therapeutics’s (NEUP) share price is $6.87, making it a Buy.
Neuphoria Therapeutics’s (NEUP) stock price is $6.87 and Neuphoria Therapeutics’s (NEUP) 50-day simple moving average is 5.50, creating a Buy signal.
Neuphoria Therapeutics’s (NEUP) stock price is $6.87 and Neuphoria Therapeutics’s (NEUP) 100-day simple moving average is 5.15, creating a Buy signal.
Neuphoria Therapeutics’s (NEUP) stock price is $6.87 and Neuphoria Therapeutics’s (NEUP) 200-day simple moving average is 4.93, creating a Buy signal.

Neuphoria Therapeutics (NEUP) Technical Indicators

Jun 09, 2025, 07:27 AM
Name
Value
Implied Action
RSI (14)
66.36
Neutral
STOCH (9,6)
74.70
Neutral
STOCHRSI (14)
88.52
Sell
MACD (12,26)
0.51
Sell
ADX (14)
42.24
Neutral
Williams %R
-19.05
Sell
CCI (14)
76.32
Neutral
ATR (14)
0.44
-
Ultimate Oscillator
48.71
Neutral
ROC
39.63
Buy
Neuphoria Therapeutics’s (NEUP) Relative Strength Index (RSI) is 66.36, creating a Neutral signal.
Neuphoria Therapeutics’s (NEUP) Trend Strength Indicator (ADX) is 42.24, creating a Neutral signal.
Neuphoria Therapeutics’s (NEUP) Commodity Channel Index (CCI) is 76.32, creating a Neutral signal.
Neuphoria Therapeutics’s (NEUP) Price Rate of Change (ROC) is 39.63, creating a Buy signal.

FAQ

Is NEUP a Buy, Hold, or Sell?
Based on NEUP’s technical indicators, NEUP is a Buy.
    What is NEUP’s RSI (14)?
    NEUP’s RSI (14) is 66.36, which suggests NEUP is a Neutral.
      What is NEUP’s MACD?
      NEUP’s MACD is 0.51, which suggests NEUP is a Sell.
        What is NEUP’s 5-day moving average?
        NEUP’s 5-day moving average is 7.01, which suggests NEUP is a Sell.
          What is NEUP’s 20-day moving average?
          NEUP 20-day moving average is 5.99, which suggests NEUP is a Buy.
            What is NEUP’s 50-day moving average?
            NEUP’s 50-day moving average is 5.50, which suggests NEUP is a Buy.
              What is NEUP’s 200-day moving average?
              NEUP’s 200-day moving average is 4.93, which suggests NEUP is a Buy.
                What is NEUP’s Williams % R (14)?
                NEUP’s Williams % R (14) is -19.05, which suggests NEUP is a Sell.
                  What is NEUP’s CCI (14)?
                  NEUP’s CCI (14) is 76.32, which suggests NEUP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis